Med Hypotheses. 1991 Nov;36(3):185-9.

Innovation vs. quality control: an 'unpublishable' clinical trial of supplemental ascorbate in incurable cancer.

Source

Vale of Leven Hospital, Alexandria, Scotland, UK.

Abstract

A computerized data bank was created recording the details of all cancer patients attending three district general hospitals in West Central Scotland over a 4.5 year period 1978-1982. At the conclusion of the trial, the records of 2804 individual patients were available for study, of whom 1826 had reached an incurable stage. 294 of these incurable cancer patients had received supplemental ascorbate at some stage in their illness, whereas 1532 had not, and served as controls. Analysis showed that the ascorbate-supplemented patients had a median overall survival time (343 days) almost double that of the controls (180 days). Our difficulties in having this simple, but important, observation published are briefly recounted in the introduction.

PMID:: 1787807; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Ascorbic Acid

LinkOut - more resources

Full Text Sources

Elsevier Science

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. [Int J Vitam Nutr Res Suppl. 1982]
Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate.
Murata A, Morishige F, Yamaguchi H. Int J Vitam Nutr Res Suppl. 1982; 23:103-13.
Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. [Proc Natl Acad Sci U S A. 1978]
Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.
Cameron E, Pauling L. Proc Natl Acad Sci U S A. 1978 Sep; 75(9):4538-42.
Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. [Proc Natl Acad Sci U S A. 1976]
Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.
Cameron E, Pauling L. Proc Natl Acad Sci U S A. 1976 Oct; 73(10):3685-9.
Review Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. [Pharmacoeconomics. 2004]
Review Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL, Figgitt DP. Pharmacoeconomics. 2004; 22(6):389-411.
Review A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. [Health Technol Assess. 2001]
Review A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N. Health Technol Assess. 2001; 5(32):1-195.

See reviews... See all...

Cited by 2 PubMed Central articles

Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance. [Free Radic Biol Med. 2011]
Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance.
Cullen JJ, Spitz DR, Buettner GR. Free Radic Biol Med. 2011 Jun 15; 50(12):1726-7. Epub 2011 Apr 1.
The prospects of vitamin C in cancer therapy. [Immune Netw. 2009]
The prospects of vitamin C in cancer therapy.
Lee WJ. Immune Netw. 2009 Oct; 9(5):147-52. Epub 2009 Oct 30.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Innovation vs. quality control: an 'unpublishable' clinical trial of supplementa...
Innovation vs. quality control: an 'unpublishable' clinical trial of supplemental ascorbate in incurable cancer.
Med Hypotheses. 1991 Nov ;36(3):185-9.

PubMed
Motor proteins: trafficking and signaling collide.
Motor proteins: trafficking and signaling collide.
Curr Biol. 2007 Sep 18 ;17(18):R804-6.

PubMed
Effect of ramipril on the incidence of diabetes (DREAM Study).
Effect of ramipril on the incidence of diabetes (DREAM Study).
Curr Atheroscler Rep. 2007 Aug ;9(2):95.

PubMed
Mindfulness and the psychology of presence.
Mindfulness and the psychology of presence.
Psychol Psychother. 2007 Sep ;80(Pt 3):367-76.

PubMed
Chiropractic and exercise for seniors with low back pain or neck pain: the desig...
Chiropractic and exercise for seniors with low back pain or neck pain: the design of two randomized clinical trials.
BMC Musculoskelet Disord. 2007 Sep 18 ;8:94.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: